Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

SVA

SINOVAC BIOTECH LTD

Pharmaceutical Preparations · SIC 2834CIK 1084201Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$0.39B
Net Income FY2025
$(0.20B)
EPS (Basic, as reported)
$-0.83
Net Margin FY2025
-51.5%
ROE FY2025
-4.5%
Total Equity
$4.44B
Shares Out
72M
Business description

SINOVAC BIOTECH LTD — Pharmaceutical Preparations. Figures are as reported in each year's original 20-F (foreign private issuer annual report) via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 72 → 386 +20.5% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue7217423024651119,3751,493448361386
Cost of revenue(22)(20)(25)(32)(67)(1,072)(684)(182)(141)(124)
Gross profit5015420521444318,303808267221262
Research & development(13)(20)(22)(24)(49)(155)(442)(345)(271)(216)
Selling, general & administrative(42)(87)(137)(121)(177)(591)(824)(466)(421)(333)
Total operating expenses(50)(109)(160)(145)(228)(749)(1,274)(870)(726)(752)
Operating income145456921617,553(466)(603)(506)(490)
Interest expense(2)(2)(1)(1)(1)(3)(1)(2)(6)(10)
Interest & investment income11222103191852933
Other income (expense), net00010(90)302367528209
Pre-tax income045477121717,56325(153)43(262)
Income tax expense(3)(8)(10)(6)(31)(3,104)(63)(105)(2)(63)
Net income(1)2622451108,467114(100)41(199)
EPS — basic($0.01)$0.45$0.34$0.63$1.06$85.20$1.08($1.06)$1.27($0.83)
EPS — diluted($0.01)$0.45$0.34$0.63$0.97$74.27$1.00($1.06)$1.27($0.83)
Shares outstanding — basic (M)5757657199991001007272
Shares outstanding — diluted (M)575765711141141141007272

Showing the latest 10 of 17 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.